Skip to main content

Find Clinical Trials

Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Sutent Rechallenge In mRCC Patients

NCT01827254

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: CHU de la Timone Marseille, Cedex 5, France

Hopital albert Michalon Grenoble, Cedex 9, France

Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire Saint-Priest-en-Jarez, France

Centre Paul Papin Angers, France

View all 18 locations

View Trial Details

Completed

Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

NCT00020540

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Surgery Branch Bethesda, Maryland, United States

View Trial Details

Completed

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

NCT00019435

Conditions: Bladder Cancer, Breast Cancer, Breast Diseases, +46 more
Locations: Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)

NCT00019955

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors

NCT00020150

Conditions: Adnexal Diseases, Astrocytoma, Brain Diseases, +73 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

NCT00276835

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma

NCT00422019

Conditions: Advanced Renal Cell Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details

Completed

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

NCT00831844

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +64 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Southern California Permanente Medical Group Downey, California, United States

Miller Children's Hospital Long Beach, California, United States

View all 105 locations

View Trial Details

Completed

Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

NCT01446224

Conditions: Adenocarcinoma, Arterial Occlusive Diseases, Arteriosclerosis, +21 more
Locations: Not specified

View Trial Details

Completed

A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816)

NCT00536588

Conditions: Bladder Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details